Metraipolis › archive › dc_22ac223f75cf

Challenges documenting racial disparities in Merkel cell carcinoma — Europe PMC PMID:36404405

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/36404405
DOI
10.1080/15384047.2022.2145842
License (as archived)
CC0-1.0
Archived
2026-10-10T03:29:17.732Z
SHA-256 of the archived text
1893420ff8d0da5c3e37f25876cfc09cc31db009b4868bce6df740e975a6fc44
Stable URL of this page
https://metraipolis.com/documento/dc_22ac223f75cf

How to cite

Challenges documenting racial disparities in Merkel cell carcinoma — Europe PMC PMID:36404405 — Europe PMC (en), https://europepmc.org/article/MED/36404405 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_22ac223f75cf (Metraipolis archive dc_22ac223f75cf, sha256 1893420ff8d0da5c3e37f25876cfc09cc31db009b4868bce6df740e975a6fc44)
BibTeX
@misc{dc22ac223f75cf,
  title = {Challenges documenting racial disparities in Merkel cell carcinoma — Europe PMC PMID:36404405},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36404405},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_22ac223f75cf; sha256 1893420ff8d0da5c3e37f25876cfc09cc31db009b4868bce6df740e975a6fc44},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/36404405. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine skin cancer that predominantly impacts White patients. Overall incidence and the proportion of minority patients with MCC are both rising. In the more common skin cancer, melanoma, racial disparities are well-documented in stage at presentation and patient survival. Whether racial and ethnic disparities exist in MCC remains unclear. The study of MCC disparities is hampered by limitations in data registries, including SEER and NCDB, and an evolving natural history due to the advent of immunotherapy. Published MCC immunotherapy clinical trials consistently reported the racial diversity among enrolled subjects but failed to include patients' ethnicities. Efforts to improve data capture in cancer registries and create multi-institutional clinical databases will allow for more effective study of racial and ethnic disparities in rare cancers like MCC. Such studies are needed to advance policies promoting equity in care.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: Cancer biology & therapy, 2022 (prima pubblicazione 2022-12-01).
Identificativi: PMID 36404405 · PMCID PMC9683062 · DOI 10.1080/15384047.2022.2145842.
Parole chiave degli autori: Survival; Immunotherapy; Health Disparities; Merkel Cell Carcinoma; Skin Cancer; Racial Disparities; Rare Diseases; Tumor Registries.
Descrittori MeSH principali: Carcinoma, Merkel Cell; Melanoma; Skin Neoplasms.
Pagina: https://europepmc.org/article/MED/36404405 — https://doi.org/10.1080/15384047.2022.2145842. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-10T03:15:26.565Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.